FDA Authorizes Novavax’s Protein-Based COVID-19 Vaccine

The New York Times (7/13, Robbins, Zimmer) reports that on Wednesday, the FDA authorized Novavax’s protein-based COVID-19 vaccine for use in adults, which, “after two years of development, the vaccine has finally overcome manufacturing problems to become...